Polo-like kinase 1 (Plk1) in non-melanoma skin cancers

Cell Cycle

Volumn 8, Issue 17, 2009, Pages 2697-2702

  Schmit, Travis L ^a   Zhong, Weixiong ^b,c   Nihal, Minakshi ^a,c   Ahmad, Nihal ^a,c  

^a UNIVERSITY OF WISCONSIN MADISON   (United States)

^b UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

^c UNIVERSITY OF WISCONSIN   (United States)

Author keywords

BCC; Mitosis; Polo like kinase; SCC; Skin cancer

Indexed keywords

CYCLIN B1; CYCLIN DEPENDENT KINASE 1; MESSENGER RNA; POLO LIKE KINASE 1; PROTEIN TYROSINE PHOSPHATASE;

APOPTOSIS; BASAL CELL CARCINOMA; CELL CYCLE ARREST; CELL GROWTH; CELL VIABILITY; CONTROLLED STUDY; HUMAN; HUMAN CELL; KERATINOCYTE; MELANOMA; MELANOMA CELL; PROTEIN EXPRESSION; REVIEW; SKIN CANCER; SQUAMOUS CELL; SQUAMOUS CELL CARCINOMA;

EID: 69749102519     PISSN: 15384101     EISSN: 15514005     Source Type: Journal    
DOI: 10.4161/cc.8.17.9413     Document Type: Review

References (31)

1. Jemal A, Siegel R, Ward E, Hao Y, Xu J, Thun MJ. Cancer statistics, 2009. CA Cancer J Clin 2009; [Epub ahead of print].
2. Giglia-Mari G, Sarasin A. TP53 mutations in human skin cancers. Hum Mutat 2003; 21:217-228 (Pubitemid 36292964)
3. Ziegler A, Jonason AS, Leffell DJ, Simon JA, Sharma HW, Kimmelman J, et al. Sunburn and p53 in the onset of skin cancer. Nature 1994; 372:773-776
4. Schmit TL, Ahmad N. Regulation of mitosis via mitotic kinases: new opportunities for cancer management. Mol Cancer Ther 2007; 6:1920-1931 (Pubitemid 47052482)
5. Archambault V, Glover DM. Polo-like kinases: conservation and divergence in their functions and regulation. Nat Rev Mol Cell Biol 2009; 10:265-275
6. Bahassie M, Conn CW, Myer DL, Hennigan RF, McGowan CH, Sanchez Y, Stambrook PJ. Mammalian Polo-like kinase 3 (Plk3) is a multifunctional protein involved in stress response pathways. Oncogene 2002; 21:6633-6640 (Pubitemid 35177042)
7. Cizmecioglu O, Warnke S, Arnold M, Duensing S, Hoffmann I. Plk2 regulated centriole duplication is dependent on its localization to the centrioles and a functional polo-box domain. Cell Cycle 2008; 7:3548-3555
8. Wang Q, Xie S, Chen J, Fukasawa K, Naik U, Traganos F, et al. Cell cycle arrest and apoptosis induced by human Polo-like kinase 3 is mediated through perturbation of microtubule integrity. Mol Cell Biol 2002; 22:3450-3459 (Pubitemid 34453984)
9. Habedanck R, Stierhof YD, Wilkinson CJ, Nigg EA. The Polo kinase Plk4 functions in centriole duplication. Nat Cell Biol 2005; 7:1140-1146
10. Schmit TL, Zhong W, Setaluri V, Spiegelman VS, Ahmad N. Targeted Depletion of Polo-Like Kinase (Plk) 1 Through Lentiviral shRNA or a Small-Molecule Inhibitor Causes Mitotic Catastrophe and Induction of Apoptosis in Human Melanoma Cells. J Invest Dermatol 2009; [Epub ahead of print].
11. Liu X, Lei M, Erikson RL. Normal cells, but not cancer cells, survive severe Plk1 depletion. Mol Cell Biol 2006; 26:2093-2108 (Pubitemid 43346913)
12. Martin BT, Strebhardt K. Polo-like kinase 1: target and regulator of transcriptional control. Cell Cycle 2006; 5:2881-2885 (Pubitemid 44953940)
13. Hurley PJ, Bunz F. ATM and ATR: components of an integrated circuit. Cell Cycle 2007; 6:414-417 (Pubitemid 46393443)
14. Smits VA, Klompmaker R, Arnaud L, Rijksen G, Nigg EA, Medema RH. Polo-like kinase-1 is a target of the DNA damage checkpoint. Nat Cell Biol 2000; 2:672-676 (Pubitemid 30742844)
15. van Vugt MA, Smits VA, Klompmaker R, Medema RH. Inhibition of Polo-like kinase-1 by DNA damage occurs in an ATM- or ATR-dependent fashion. J Biol Chem 2001; 276:41656-41660 (Pubitemid 37371057)
16. Jackson MW, Agarwal MK, Yang J, Bruss P, Uchiumi T, Agarwal ML, et al. p130/p107/p105Rb-dependent transcriptional repression during DNA-damage-induced cell cycle exit at G2. J Cell Sci 2005; 118:1821-1832 (Pubitemid 40723827)
17. Ando K, Ozaki T, Yamamoto H, Furuya K, Hosoda M, Hayashi S, et al. Polo-like kinase 1 (Plk1) inhibits p53 function by physical interaction and phosphorylation. J Biol Chem 2004; 279:25549-25561 (Pubitemid 38756815)
18. Chen J, Dai G, Wang YQ, Wang S, Pan FY, Xue B, et al. Polo-like kinase 1 regulates mitotic arrest after UV irradiation through dephosphorylation of p53 and inducing p53 degradation. FEBS Lett 2006; 580:3624-3630 (Pubitemid 43902798)
19. Hahn H, Wicking C, Zaphiropoulous PG, Gailani MR, Shanley S, Chidambaram A, et al. Mutations of the human homolog of Drosophila patched in the nevoid basal cell carcinoma syndrome. Cell 1996; 85:841-851 (Pubitemid 26192135)
20. Johnson RL, Rothman AL, Xie J, Goodrich LV, Bare JW, Bonifas JM, et al. Human homolog of patched, a candidate gene for the basal cell nevus syndrome. Science 1996; 272:1668-1671 (Pubitemid 26200029)
21. Gailani MR, Stahle-Backdahl M, Leffell DJ, Glynn M, Zaphiropoulos PG, Pressman C, et al. The role of the human homologue of Drosophila patched in sporadic basal cell carcinomas. Nat Genet 1996; 14:78-81. (Pubitemid 26301550)
22. Xie J, Murone M, Luoh SM, Ryan A, Gu Q, Zhang C, et al. Activating Smoothened mutations in sporadic basal-cell carcinoma. Nature 1998; 391:90-92 (Pubitemid 28079221)
23. Philipp M, Caron MG. Hedgehog signaling: is Smo a G protein-coupled receptor? Curr Biol 2009; 19:125-127
24. Bai CB, Auerbach W, Lee JS, Stephen D, Joyner AL. Gli2, but not Gli1, is required for initial Shh signaling and ectopic activation of the Shh pathway. Development 2002; 129:4753-4761 (Pubitemid 35277202)
25. Dahmane N, Lee J, Robins P, Heller P, Altaba A. Activation of the transcription factor Gli1 and the Sonic hedgehog signalling pathway in skin tumours. Nature 1997; 389:876-881 (Pubitemid 27462984)
26. Tsai KY, Tsao H. The genetics of skin cancer. Am J Med Genet C Semin Med Genet 2004; 131:82-92.
27. Barnes EA, Kong M, Ollendorff V, Donoghue DJ. Patched1 interacts with cyclin B1 to regulate cell cycle progression. EMBO J 2001; 20:2214-2223 (Pubitemid 32410591)
28. Lodygin D, Yazdi AS, Sander CA, Herzinger T, Hermeking H. Analysis of 14-3-3sigma expression in hyperproliferative skin diseases reveals selective loss associated with CpG-methylation in basal cell carcinoma. Oncogene 2003; 22:5519-5524 (Pubitemid 37072207)
29. Boukamp P. Non-melanoma skin cancer: what drives tumor development and progression? Carcinogenesis 2005; 26:1657-1667
30. Jin Y, Jin C, Salemark L, Wennerberg J, Persson B, Jonsson N. Clonal chromosome abnormalities in premalignant lesions of the skin. Cancer Genet Cytogenet 2002; 136:48-52. (Pubitemid 34876968)
31. Rehman I, Takata M, Wu YY, Rees JL. Genetic change in actinic keratoses. Oncogene 1996; 12:2483-2490